GranuFlo Lawsuit Filings May Rise as Product Liability Deadlines Approach
Time may be running out for some individuals hoping to join the NaturaLyte and GranuFlo lawsuit litigation, depending on their state’s statue of limitations.
According to certain state regulations for filing product liability lawsuits, some potential claimants may be required to come forward before the end of March 2014; two years after Fresenius Medical Care issued an Urgent Product Notification warning the public about the possible association between its dialysis drugs and the risk for heart attack, stroke, sudden cardiac death and other serious heart problems. Among other things, the March 29, 2012 alert warned facilities using GranuFlo and NaturaLyte in U.S. dialysis clinics to monitor for elevated bicarbonate levels in patients. Both of these medications contain a high level of an ingredient the body converts to bicarbonate, which may result in a condition known as metabolic alkalosis.
460 Lawsuits Follow GranuFlo Recall
Two months later, the notification was given Class I recall status by the U.S. Food and Drug Administration (FDA), which is its most serious category of recalls and only announced when the agency determines that a product may cause serious side effects and/or death.
In the two-year wake of this NaturaLyte and GranuFlo recall, the number of lawsuits alleging fatal and near-fatal heart problems may be on the rise. Several states require that claims be filed within two years after the potential plaintiff makes a connection between their injury and its cause.
According to a recent update from the U.S. Judicial Panel on Multidistrict Litigation (JPML), at least 460 GranuFlo and NaturaLyte recall lawsuits had been field in a federal proceeding established in the U.S. District Court, District of Massachusetts. These cases similarly allege that Fresenius not only failed to warn the general public about side effects that may be associated with its dialysis drugs, but also had knowledge of vital safety information and concealed it from the general public.
Hundreds of plaintiffs involved in federal and state-filed GranuFlo lawsuits point to an internal memo sent by Fresenius in November 2011 that warned of 941 patient deaths that occurred after dialysis treatments using the acid concentrates.
Are You Running Out of Time to File a GranuFlo Lawsuit? Find Out Today.
Call one of our attorneys today to find out if your state’s deadline for filing a NaturaLyte or GranuFlo lawsuit is approaching. Call us now at (877) 779-1414.